Un año mas, Clarke,Modet & Cº
España participa en el informe Anual de Asebio, que recoge
los últimos datos del sector biotecnológico
El documento elaborado por la Asociación Española
de Bioempresas ( ASEBIO) en colaboración con el Parque
Científico de Madrid y con Clarke, Modet & Cº
España, se posiciona ya como uno de los 5 informes de mayor
relevancia en el campo de la innovación.
Su edición de 2015 se presentaba ayer en al sede de la
calle Serrano y arrojaba datos tan destacados como que el
año pasado se publicarn 905 patentes en el sector
biotecnológico con una caída del 7.27%.
Marketing Authorization (MA) process in Mexico involves the direct or indirect participation of IP authority.
While it is true that each stage of the Marketing Authorization process includes particular steps, most of them have well-stablished guidelines; however, the stages related to IP rights are still under refinement.
In order to understand the relationship between actual IP rights and the MA prosecution process, Clarke Modet & Co offers wide range solutions from the IP point of v
Directed to in-house patent and legal professionals of pharmaceutical companies and their subsidiaries, to understand the relationship between IP rights and the market authorization prosecution process for a drug in Mexico.
IP services during Marketing Authorization (MA) process in Mexico:
Background: Search of patent documents related to a drug, Linkage system
Processing: Filling response to office actions from COFEPRIS related to IP matters
Monitoring: Importations and exportations vigilance
The Turkish Ministry of Health ("Ministry") and Social Security Institute ("Institute") announced that according to a new cost savings action plan, pharmaceuticals imported under named-patient sales will occur through the Institute, rather that the Turkish Pharmacists Association ("Association") from 2 May 2017.
The Turkish Competition Board ("Board") recently published a short form decision concluding that the Turkish Pharmacists Association had abused its dominant market position when procuring pharmaceuticals from abroad by executing exclusivity agreements with pharmaceutical suppliers.
Turkey has amended principles for health-related R&D tenders. The changes apply to procurement of R&D services by the Ministry of Health, within the scope of Article 3(f) of Public Tender Act number 4734.
After studying bioengineering and completing a PhD in the San Francisco Bay Area and a two-year postdoctoral research fellowship in London, Mark has spent the past four years analysing global health policy.
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).